IBB vs SCHG
iShares Biotechnology ETF vs Schwab US Large-Cap Growth ETF
- • SCHG has the lower expense ratio at 0.04% vs 0.44% for IBB.
- • SCHG pays a higher dividend yield (0.40%).
Side-by-side metrics
| Metric | IBB | SCHG |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.04% |
Dividend yield Trailing 12-month yield. | 0.16% | 0.40% |
AUM Assets under management — bigger funds are typically more liquid. | $11.50B | $61.69B |
YTD return | 30.22% | 4.82% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.60 | 1.19 |
P/E ratio | 25.48 | 27.01 |
Last price | $217.75 | $34.60 |
Inception | — | — |
Issuer | iShares | Schwab |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
SCHG top holdings
| AAPL | Apple Inc | 12.07% |
| NVDA | NVIDIA Corp | 11.88% |
| MSFT | Microsoft Corp | 9.30% |
| AMZN | Amazon.com Inc | 5.66% |
| AVGO | Broadcom Inc | 4.07% |
| GOOGL | Alphabet Inc Class A | 3.94% |
| META | Meta Platforms Inc Class A | 3.77% |
| GOOG | Alphabet Inc Class C | 3.17% |
| LLY | Eli Lilly and Co | 3.16% |
| TSLA | Tesla Inc | 3.14% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About SCHG
SCHG (Schwab US Large-Cap Growth ETF) is Large-cap US growth at low cost. Managed by Schwab, the fund carries $61.7B in assets under management, an expense ratio of 0.04%, a dividend yield of 0.40%. Its largest holding is Apple Inc (AAPL), which represents 12.1% of the portfolio. Real Estate is the fund's largest sector exposure at 0.3%.